ClinicalTrials.Gov Registry Needs Legislative Boost, JAMA Editorial Says
Executive Summary
Congress needs to add funding and enforcement tools to the legislation creating the ClinicalTrials.gov clinical trials registry, a "special communication" in the July 23/30 issue of the Journal of the American Medical Association says
You may also be interested in...
ClinicalTrials.gov Noncompliance Remains An FDA Concern
The pharmaceutical industry's failure to list cancer trial information on ClinicalTrials.gov remains a concern to FDA, Oncology Drug Products Division Director Richard Pazdur, MD, said May 12
ClinicalTrials.gov Noncompliance Remains An FDA Concern
The pharmaceutical industry's failure to list cancer trial information on ClinicalTrials.gov remains a concern to FDA, Oncology Drug Products Division Director Richard Pazdur, MD, said May 12
ClinicalTrials.gov Postings By Industry Increase, But Still Appear Incomplete
The ClinicalTrials.gov database includes over 650 open protocols sponsored by the pharmaceutical industry as of June 17